Compare Nuvalent Inc (NUVL) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Stryker Corporation — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Stryker Corporation trades at $319.04 (market cap $122.35B). The key difference: Stryker Corporation is far larger — about 12.5× Nuvalent Inc's market cap, and Stryker Corporation pays a 1% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | SYK | |
|---|---|---|
Market Cap | $9.81B | $122.35B |
Sector | Technology | Technology |
52-Week High | $123.96 | $403.53 |
52-Week Low | $72.16 | $282.58 |
Enterprise Value | $8.52B | $134.10B |
Dividend Yield | — | 1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
